LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 127.04 Million USD | 15.31% |
| 2022 | 104.89 Million USD | 3.47% |
| 2021 | 101.38 Million USD | 19.81% |
| 2020 | 84.61 Million USD | 5.97% |
| 2019 | 79.85 Million USD | 8.0% |
| 2018 | 73.93 Million USD | 4.59% |
| 2017 | 70.69 Million USD | 12.33% |
| 2016 | 62.93 Million USD | 16.19% |
| 2015 | 54.16 Million USD | 11.84% |
| 2014 | 48.43 Million USD | 7.35% |
| 2013 | 45.11 Million USD | 10.39% |
| 2012 | 40.86 Million USD | 1.59% |
| 2011 | 40.22 Million USD | -3.58% |
| 2010 | 41.71 Million USD | 11.84% |
| 2009 | 37.3 Million USD | 10.03% |
| 2008 | 33.9 Million USD | 10.41% |
| 2007 | 30.7 Million USD | 21.56% |
| 2006 | 25.26 Million USD | 15.88% |
| 2005 | 21.8 Million USD | 18.46% |
| 2004 | 18.4 Million USD | -10.94% |
| 2003 | 20.66 Million USD | 83.13% |
| 2002 | 11.28 Million USD | 46.22% |
| 2001 | 7.71 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 37.17 Million USD | 0.49% |
| 2024 Q2 | 36.99 Million USD | 0.9% |
| 2024 Q1 | 36.66 Million USD | 15.38% |
| 2023 FY | 120.95 Million USD | 15.31% |
| 2023 Q1 | 30.88 Million USD | 18.53% |
| 2023 Q2 | 32.08 Million USD | 3.9% |
| 2023 Q3 | 30.81 Million USD | -3.96% |
| 2023 Q4 | 31.77 Million USD | 3.12% |
| 2022 FY | 104.89 Million USD | 3.47% |
| 2022 Q2 | 27.81 Million USD | 7.12% |
| 2022 Q1 | 25.96 Million USD | 0.02% |
| 2022 Q4 | 26.05 Million USD | 3.93% |
| 2022 Q3 | 25.07 Million USD | -9.85% |
| 2021 Q2 | 26.76 Million USD | 12.45% |
| 2021 Q3 | 24.86 Million USD | -7.08% |
| 2021 FY | 101.38 Million USD | 19.81% |
| 2021 Q4 | 25.95 Million USD | 4.38% |
| 2021 Q1 | 23.79 Million USD | -2.47% |
| 2020 Q3 | 22.7 Million USD | 33.33% |
| 2020 FY | 84.61 Million USD | 5.97% |
| 2020 Q4 | 24.4 Million USD | 7.48% |
| 2020 Q1 | 20.48 Million USD | 2.89% |
| 2020 Q2 | 17.02 Million USD | -16.86% |
| 2019 Q1 | 19.46 Million USD | 1.28% |
| 2019 Q3 | 20.16 Million USD | -0.73% |
| 2019 Q4 | 19.9 Million USD | -1.28% |
| 2019 FY | 79.85 Million USD | 8.0% |
| 2019 Q2 | 20.31 Million USD | 4.37% |
| 2018 Q3 | 17.25 Million USD | -9.15% |
| 2018 Q1 | 18.47 Million USD | 1.22% |
| 2018 FY | 73.93 Million USD | 4.59% |
| 2018 Q4 | 19.21 Million USD | 11.38% |
| 2018 Q2 | 18.99 Million USD | 2.8% |
| 2017 FY | 70.69 Million USD | 12.33% |
| 2017 Q4 | 18.25 Million USD | 3.84% |
| 2017 Q3 | 17.57 Million USD | 0.35% |
| 2017 Q2 | 17.51 Million USD | 0.94% |
| 2017 Q1 | 17.35 Million USD | 7.16% |
| 2016 FY | 62.93 Million USD | 16.19% |
| 2016 Q3 | 17.01 Million USD | 10.75% |
| 2016 Q2 | 15.36 Million USD | 7.04% |
| 2016 Q4 | 16.19 Million USD | -4.85% |
| 2016 Q1 | 14.35 Million USD | -0.33% |
| 2015 Q4 | 14.4 Million USD | 6.56% |
| 2015 FY | 54.16 Million USD | 11.84% |
| 2015 Q3 | 13.51 Million USD | 2.94% |
| 2015 Q2 | 13.13 Million USD | 0.1% |
| 2015 Q1 | 13.11 Million USD | 2.25% |
| 2014 Q3 | 12 Million USD | -3.01% |
| 2014 Q4 | 12.82 Million USD | 6.87% |
| 2014 FY | 48.43 Million USD | 7.35% |
| 2014 Q1 | 11.22 Million USD | -6.12% |
| 2014 Q2 | 12.37 Million USD | 10.26% |
| 2013 Q3 | 10.71 Million USD | -4.64% |
| 2013 Q4 | 11.95 Million USD | 11.57% |
| 2013 Q1 | 11.2 Million USD | 7.36% |
| 2013 FY | 45.11 Million USD | 10.39% |
| 2013 Q2 | 11.23 Million USD | 0.28% |
| 2012 Q3 | 10.01 Million USD | -5.03% |
| 2012 Q4 | 10.43 Million USD | 4.22% |
| 2012 Q2 | 10.54 Million USD | 6.84% |
| 2012 Q1 | 9.87 Million USD | 3.64% |
| 2012 FY | 40.86 Million USD | 1.59% |
| 2011 FY | 40.22 Million USD | -3.58% |
| 2011 Q1 | 10.15 Million USD | -1.89% |
| 2011 Q2 | 10.37 Million USD | 2.16% |
| 2011 Q3 | 10.18 Million USD | -1.8% |
| 2011 Q4 | 9.52 Million USD | -6.48% |
| 2010 Q3 | 10.39 Million USD | -2.42% |
| 2010 Q4 | 10.34 Million USD | -0.49% |
| 2010 FY | 41.71 Million USD | 11.84% |
| 2010 Q1 | 10.31 Million USD | 1.43% |
| 2010 Q2 | 10.65 Million USD | 3.28% |
| 2009 Q2 | 9.12 Million USD | 10.36% |
| 2009 Q1 | 8.26 Million USD | -1.89% |
| 2009 FY | 37.3 Million USD | 10.03% |
| 2009 Q4 | 10.17 Million USD | 4.41% |
| 2009 Q3 | 9.74 Million USD | 6.81% |
| 2008 FY | 33.9 Million USD | 10.41% |
| 2008 Q2 | 8.88 Million USD | 4.68% |
| 2008 Q3 | 8.1 Million USD | -8.81% |
| 2008 Q4 | 8.42 Million USD | 3.97% |
| 2008 Q1 | 8.48 Million USD | 4.25% |
| 2007 FY | 30.7 Million USD | 21.56% |
| 2007 Q4 | 8.14 Million USD | 7.41% |
| 2007 Q2 | 7.61 Million USD | 3.3% |
| 2007 Q3 | 7.58 Million USD | -0.42% |
| 2007 Q1 | 7.37 Million USD | 11.75% |
| 2006 Q1 | 6.31 Million USD | -19.88% |
| 2006 Q4 | 6.59 Million USD | 5.33% |
| 2006 FY | 25.26 Million USD | 15.88% |
| 2006 Q3 | 6.26 Million USD | 2.72% |
| 2006 Q2 | 6.09 Million USD | -3.41% |
| 2005 Q3 | 7.82 Million USD | 3.85% |
| 2005 Q4 | 7.87 Million USD | 0.72% |
| 2005 Q2 | 7.53 Million USD | 0.39% |
| 2005 FY | 21.8 Million USD | 18.46% |
| 2005 Q1 | 7.5 Million USD | 14.61% |
| 2004 FY | 18.4 Million USD | -10.94% |
| 2004 Q4 | 6.54 Million USD | -0.02% |
| 2004 Q1 | 6.54 Million USD | 0.0% |
| 2004 Q3 | 6.54 Million USD | 0.0% |
| 2004 Q2 | 6.54 Million USD | 0.0% |
| 2003 FY | 20.66 Million USD | 83.13% |
| 2002 FY | 11.28 Million USD | 46.22% |
| 2001 FY | 7.71 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -125.644% |
| AngioDynamics, Inc. | 154.69 Million USD | 17.873% |
| AtriCure, Inc. | 300.37 Million USD | 57.703% |
| Avinger, Inc. | 2 Million USD | -6242.936% |
| Azenta, Inc. | 263.14 Million USD | 51.718% |
| BioLife Solutions, Inc. | 46.75 Million USD | -171.751% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 94.612% |
| Daxor Corporation | 1.1 Million USD | -11413.902% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -1299.372% |
| Femasys Inc. | 691.9 Thousand USD | -18262.309% |
| GlucoTrack, Inc. | -13 Thousand USD | 977400.0% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -108.736% |
| Hologic, Inc. | 2.22 Billion USD | 94.297% |
| ICU Medical, Inc. | 739.87 Million USD | 82.828% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 97.314% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -660.395% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 106569.509% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 106569.509% |
| Masimo Corporation | 1 Billion USD | 87.339% |
| Microbot Medical Inc. | -106 Thousand USD | 119957.547% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -283.892% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 78.24% |
| Nephros, Inc. | 8.4 Million USD | -1411.588% |
| NovoCure Limited | 381.05 Million USD | 66.659% |
| NEXGEL, Inc. | 619 Thousand USD | -20424.879% |
| NEXGEL, Inc. | 619 Thousand USD | -20424.879% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 22868.638% |
| OraSure Technologies, Inc. | 179.42 Million USD | 29.189% |
| Pro-Dex, Inc. | 14.55 Million USD | -773.129% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 10626.015% |
| Predictive Oncology Inc. | 1.14 Million USD | -10993.105% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -2091.34% |
| QuidelOrtho Corporation | 1.49 Billion USD | 91.498% |
| Repligen Corporation | 315.22 Million USD | 59.696% |
| Sanara MedTech Inc. | 57.13 Million USD | -122.358% |
| STAAR Surgical Company | 252.65 Million USD | 49.714% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 14355.179% |
| Utah Medical Products, Inc. | 30.03 Million USD | -322.961% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 93.909% |
| Jin Medical International Ltd. | 6.78 Million USD | -1772.544% |